Basal Cell Adenoma and Basal Cell Adenocarcinoma: a 50-year Experience From a Single Institution
- PMID: 35947346
- PMCID: PMC9729486
- DOI: 10.1007/s12105-022-01484-z
Basal Cell Adenoma and Basal Cell Adenocarcinoma: a 50-year Experience From a Single Institution
Abstract
Background: Basal cell adenoma (BCA) and adenocarcinoma (BCAd) are two of the least frequent salivary gland tumors. We describe the largest series of these neoplasms, spanning over a period of 50 years (1970-2020), diagnosed and treated in a single Institution.
Methods: Sixty-eight cases were identified. Clinical and pathological data were collected and correlated with outcome.
Results: Forty-one BCA and 27 BCAd were identified. BCA cases had almost pristine prognosis, with only a relapse in a tumor inadequately excised. Ten patients with BCAd developed metastases, and 14 died from the disease. The 2-year and 5-year survival was of 76% and 42%.
Conclusions: The importance of adequate excision is reinforced in BCA, with no recurrences occurring when margins were negative. Contrary to previous reports, BCAd was not associated with a good prognosis. A better understanding of the genetics of these neoplasms may identify therapeutic options when dealing with inoperable or metastatic disease.
Keywords: Basal cell adenocarcinoma; Basal cell adenoma; Carcinoma ex pleomorphic adenoma; Head and neck neoplasms; Otorhinolaryngologic neoplasms; Salivary gland.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
The authors have no relevant financial or non-financial interests to disclose.
Figures




Similar articles
-
Basal cell adenoma and basal cell adenocarcinoma of the parotid gland: clinical findings and surgical outcomes in a single-institution study.World J Surg Oncol. 2024 Apr 18;22(1):102. doi: 10.1186/s12957-024-03378-6. World J Surg Oncol. 2024. PMID: 38637826 Free PMC article.
-
Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2.Cancer. 1998 Feb 1;82(3):439-47. Cancer. 1998. PMID: 9452259
-
Basal Cell Adenoma and Basal Cell Adenocarcinoma.Surg Pathol Clin. 2021 Mar;14(1):25-42. doi: 10.1016/j.path.2020.09.005. Epub 2021 Jan 5. Surg Pathol Clin. 2021. PMID: 33526221 Review.
-
Wnt/β-catenin signal alteration and its diagnostic utility in basal cell adenoma and histologically similar tumors of the salivary gland.Pathol Res Pract. 2018 Apr;214(4):586-592. doi: 10.1016/j.prp.2017.12.016. Epub 2018 Jan 3. Pathol Res Pract. 2018. PMID: 29496310
-
Basal Cell Adenoma of the Parotid Gland.Kathmandu Univ Med J (KUMJ). 2020 Oct.-Dec.;18(72):434-436. Kathmandu Univ Med J (KUMJ). 2020. PMID: 34165108 Review.
Cited by
-
Basal cell adenoma and basal cell adenocarcinoma of the parotid gland: clinical findings and surgical outcomes in a single-institution study.World J Surg Oncol. 2024 Apr 18;22(1):102. doi: 10.1186/s12957-024-03378-6. World J Surg Oncol. 2024. PMID: 38637826 Free PMC article.
-
Basal cell adenocarcinoma in the retromolar trigone: A case report.Imaging Sci Dent. 2025 Mar;55(1):96-101. doi: 10.5624/isd.20240226. Epub 2025 Mar 10. Imaging Sci Dent. 2025. PMID: 40191395 Free PMC article.
-
Association of Membranous Basal Cell Adenoma and Basal Cell Adenocarcinoma With Brooke-Spiegler Syndrome.Cureus. 2024 Sep 6;16(9):e68819. doi: 10.7759/cureus.68819. eCollection 2024 Sep. Cureus. 2024. PMID: 39376856 Free PMC article.
References
-
- WHO Classification of Head and Neck Tumours [Internet; beta version ahead of print] [Internet]. (2022) 5th ed. Lyon (France): International Agency for Research on Cancer. https://tumourclassification.iarc.who.int/chapters/52. Accessed 10 July 2022
-
- Muller S, Barnes L. Basal cell adenocarcinoma of the salivary glands: report of seven cases and review of the literature. Cancer Interdiscip Int J Am Cancer Soc. 1996;78:2471–2477. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical